Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Lin YT, Chen JS, Liao WY, Ho CC, et al. Clinical Outcomes and Secondary Epidermal Growth Factor Receptor (EGFR) T790M Mutation among First-line Gefitinib, Erlotinib and Afatinib-treated Non-small Cell Lung Cancer Patients with Activating EGFR Mutations. Int J Cancer 2018 Nov 28. doi: 10.1002/ijc.32025.
PMID: 30485437


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016